Chronic diseases and even aging itself are known to damage the body by dysregulated inflammatory processes. Dysregulated expression of the pro-inflammatory cytokine and chemokine genes are known to contribute to chronic inflammatory diseases. Recently, endogenous non-coding RNA (ncRNA) molecules, including long non-coding RNAs (LncRNAs) and microRNAs (miRNAs, miRs) have emerged as important targets in the frontier of biomedical research. These non-coding RNAs have been proven to be key regulators of gene expression. The ability to detect non-coding RNAs in biofluids has highlighted their usefulness as non-invasive markers of diseases, including lung diseases. The expression of specific non-coding RNAs is altered in many lung diseases and their levels in the circulation often reflect the changes in expression of their lung-specific counterparts. Therefore, exploiting these biomolecules as diagnostic tools seems an obvious goal. Our goal is to investigate the role of non-coding RNAs in Cystic Fibrosis lung disease and develop novel anti-inflammatory therapeutics for pulmonary disorders.



Publication List
Dr. Biswas Bio
USU Office of Research




ongoing research projects


partners in the last five years


student publications in the last 40 years


faculty publications in 11 different journals in the last 15 years